CompletedNCT00295048
Cognitive Remediation for Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BaltimoreSchizophreniaBehavioural studyAges 18–50
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT01781923
Cognitive Remediation in 22q11DS
Official study title
A Remediation Program for Children at High-Risk of Schizophrenia: 22q11.2 Deletion Syndrome
This study has finished and is no longer accepting participants.
In DurhamSchizophreniaBehavioural studyAges 11–17
CompletedNCT01988714
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
This study has finished and is no longer accepting participants.
In San FranciscoSchizophreniaPlacebo comparisonAges 18–65
WithdrawnNCT03407950
Cognitive Remediation Program for Hospitalized in the Long Term people with Deficit Schizophrenia
Official study title
Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia : Impact on the Capacities of Autonomy
This study was withdrawn before enrollment.
In MontpellierSchizophreniaBehavioural studyAges 18–60
CompletedNCT01078129
Cognitive Remediation Therapy and Schizophrenia
Official study title
Efficacy of Hierarchized Computer-assisted Cognitive Remediation Therapy in Schizophrenia
This study has finished and is no longer accepting participants.
In BronSchizophreniaBehavioural studyAges 18–40
CompletedNCT03695614
Cognitive Remediation Therapy for people with Late-Life Schizophrenia
What is this study about?
Researchers studied training for memory, attention and thinking skills to find out how it affected memory, attention and other thinking skills in older adults with schizophrenia.
This study has finished and is no longer accepting participants.
In TorontoSchizophreniaInterventional studyAges 55+
CompletedNCT02341131
Cognitive Remediation Therapy in Schizophrenia: Effects on BDNF Levels
Official study title
BDNF as a Potential Biomarker for Cognitive Remediation Therapy in Schizophrenia
This study has finished and is no longer accepting participants.
In BarcelonaSchizophreniaBehavioural studyAges 18–65
CompletedNCT00339170
Cognitive Training and Enhanced Supported Employment in Schizophrenia
What is this study about?
This study assessed quality of life.
This study has finished and is no longer accepting participants.
In New HavenSchizophreniaBehavioural studyAges 20+
TerminatedNCT01598896
Combination of Dronabinol and Clonidine for Cannabis Dependence in people with Schizophrenia
Official study title
Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia
This study ended early.
In BelmontSchizophreniaMedication studyAges 18–45
CompletedNCT00712686
Comparative Study of Aripiprazole and Olanzapine in the Treatment of people with Acute Schizophrenia
Official study title
A Multicenter, Double-Blind, Randomized, Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–65
CompletedNCT01213836
Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in people with Stable Schizophrenia
Official study title
A Phase IV Prospective, Double-blind, Double-dummy, Randomised, Crossover Study to Assess the Impact on Daily Cognitive Functioning of Quetiapine Fumarate Immediate Release (Seroquel IR®) Dosed Twice Daily and Quetiapine Fumarate Extended Release (Seroquel XR®) Dosed Once Daily in the Evening in Patients With Stable Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including ViennaSchizophreniaMedication studyAges 18–50
CompletedNCT02360319
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
Official study title
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonSchizophreniaMedication studyAges 18–35
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.